Literature DB >> 1993689

The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs.

P Gillis1, J S Malter.   

Abstract

Selective mRNA degradation is an important control point in the transient expression of a variety of mRNAs coding for growth regulators. A variety of labile mRNAs coding for lymphokines, cytokines, and oncogenes contain within their 3'-untranslated region an AU-rich region shown to destabilize these messages. We recently identified a cytosolic protein, adenosine-uridine binding factor (AUBF), which complexes with four tandem AUUUA reiterations of a synthetic RNA transcript. We now show that AUBF forms RNase T1-resistant band-shifted complexes with a variety of in vitro transcribed mRNAs including granulocyte-macrophage colony-stimulating factor, interferon-gamma, interleukin-3, c-fos, and v-myc. Formation of complexes was specifically inhibited by AUUUA containing RNA, but not by irrelevant RNA. After brief ultraviolet light-induced cross-linking, AUBF.RNA complexes with the exception of c-fos comigrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Mutations within the AUUUA motifs demonstrate that both nucleotide sequence and secondary structure are important in AUBF.AUUUA RNA complex formation. Based upon these data, we suggest AUBF may interact with a variety of labile mRNAs with multiple AUUUA reiterations or single reiterations within an AU-rich 3'-untranslated region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993689

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.

Authors:  T Bakheet; M Frevel; B R Williams; W Greer; K S Khabar
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique.

Authors:  S A Brooks; W F Rigby
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

Review 3.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

4.  5' untranslated sequences modulate rapid mRNA degradation mediated by 3' AU-rich element in v-/c-fos recombinants.

Authors:  N Roy; G Laflamme; V Raymond
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

Review 5.  The regulation of AβPP expression by RNA-binding proteins.

Authors:  Cara J Westmark; James S Malter
Journal:  Ageing Res Rev       Date:  2012-04-05       Impact factor: 10.895

Review 6.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

7.  Viral manipulation of host mRNA decay.

Authors:  Liang Guo; Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Future Virol       Date:  2018-02-23       Impact factor: 1.831

8.  AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A).

Authors:  C A Lagnado; C Y Brown; G J Goodall
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Rapid mRNA degradation mediated by the c-fos 3' AU-rich element and that mediated by the granulocyte-macrophage colony-stimulating factor 3' AU-rich element occur through similar polysome-associated mechanisms.

Authors:  E Winstall; M Gamache; V Raymond
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

10.  Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells.

Authors:  D W Kimberlin; S A Willis; G H McCracken; P D Nisen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.